Ranbaxy Pay-For-Delay Trial Kicks Off In Pa. Court
A Pennsylvania federal jury on Wednesday heard opening arguments in a closely watched pay-for-delay suit accusing drugmaker Ranbaxy of violating antitrust laws by accepting a settlement with rival Cephalon that improperly...To view the full article, register now.
Already a subscriber? Click here to view full article